- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06295783
Prospective Evaluation of the Relation Between Different Questionnaires Measuring Radiation-induced Side-effect
February 29, 2024 updated by: M.D. Anderson Cancer Center
To learn more about how you would rate the intensity or severity of your symptoms during or after radiation therapy using questionnaires with different rating scales.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Primary Objectives:
• To investigate how different toxicity questionnaires with different scoring systems can be reliably translated to each other by estimating different measures of correlation between items and summary scores across different questionnaires.
Study Type
Observational
Enrollment (Estimated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amy Moreno, MD
- Phone Number: (713) 745-4590
- Email: akmoreno@mdanderson.org
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- MD Anderson Cancer Center
-
Contact:
- Amy Moreno, MD
- Phone Number: 713-745-4590
- Email: akmoreno@mdanderson.org
-
Principal Investigator:
- Amy Moreno, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Head and Neck Cancer (HNC) participants undergoing active radiation therapy.
Description
Inclusion Criteria:
- Age ≥18 years
- English as a primary language
- Participants with a diagnosis of HNC undergoing active curative RT or having received curative RT within the past 5 years at MD Anderson
- Ability to complete the survey(s) of their own volition
Exclusion Criteria:
- Age < 18 years
- Non-English speaking participants
- Participants who are receiving or have received RT in a non-HN site.
- Participants in follow up and over 5 years from post-treatment
- Neurocognitive deficits that render patients unable to complete the survey(s) on their own.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Head and Neck Cancer (HNC) Questionnaire
Participants will be asked to fill out three head and neck cancer (HNC) questionnaires during your visits to the clinic:
|
Given by Questionnaire
Given by Questionnaire
Given by Questionnaire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety and adverse events (AEs)
Time Frame: Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)
|
Through study completion; an average of 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amy Moreno, MD, M.D. Anderson Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 31, 2024
Primary Completion (Estimated)
February 1, 2025
Study Completion (Estimated)
February 1, 2027
Study Registration Dates
First Submitted
February 29, 2024
First Submitted That Met QC Criteria
February 29, 2024
First Posted (Estimated)
March 6, 2024
Study Record Updates
Last Update Posted (Estimated)
March 6, 2024
Last Update Submitted That Met QC Criteria
February 29, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2023-1059
- NCI-2024-01955 (Other Identifier: NCI-CTRP Clinical Registry)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation
-
Instituto de Cardiologia do Rio Grande do SulCompletedRadiation Injury | Exposure to Ionizing Radiation | Occupational Exposure to RadiationBrazil
-
Korea Institute of Radiological & Medical SciencesActive, not recruitingRadiation Effects | Neoplasms, Radiation-Induced | Occupational Exposure to Radiation | Leukemia, Radiation-InducedKorea, Republic of
-
North Texas Veterans Healthcare SystemCompletedRadiation Protection | Radiation MonitoringUnited States
-
National Cancer Institute (NCI)CompletedRadiation-Induced Neoplasms | Breast+Neoplasm+Radiation+Etiology | Thyroid+Neoplasm+Radiation+EtiologyUnited States
-
Affiliated Hospital to Academy of Military Medical...UnknownRadiation Injuries, ExperimentalChina
-
Pluristem Ltd.Unknown
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruitingChronic Radiation Injury
-
Neumedicines Inc.Department of Health and Human ServicesCompletedHematopoietic Syndrome Due to Acute Radiation SyndromeUnited States
-
McMaster UniversityNot yet recruitingOxidative Stress | Radiation Exposure | DNA Damage, Radiation Induced
-
Original BioMedicals Co. Ltd.UnknownAcute Radiation SyndromeUnited States
Clinical Trials on MDASI-HN
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsUnknown
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompletedHeart Failure | CancerUnited States
-
Duke UniversityActive, not recruitingHead and Neck CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterRecruiting
-
M.D. Anderson Cancer CenterNovartisUnknown
-
Memorial Sloan Kettering Cancer CenterRecruitingGastric Cancer | Gastroesophageal Junction Adenocarcinoma | GastroEsophageal CancerUnited States
-
Temple UniversityWithdrawnVenous ThrombosisUnited States
-
Anabio R&DHanoi Medical UniversityRecruitingRespiratory Disease | Respiratory Infections in ChildrenVietnam